Aquilo Capital Management as of March 31, 2024
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 10 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals (ARWR) | 19.5 | $26M | 909k | 28.60 | |
| Regenxbio Inc equity us cm (RGNX) | 14.3 | $19M | 906k | 21.07 | |
| Blueprint Medicines (BPMC) | 13.0 | $17M | 182k | 94.86 | |
| Arvinas Ord (ARVN) | 12.6 | $17M | 406k | 41.28 | |
| Kymera Therapeutics (KYMR) | 11.7 | $16M | 389k | 40.20 | |
| Silence Therapeutics Ads (SLN) | 9.3 | $12M | 574k | 21.60 | |
| Merus N V (MRUS) | 8.6 | $12M | 255k | 45.03 | |
| Sutro Biopharma (STRO) | 4.9 | $6.6M | 1.2M | 5.65 | |
| Precision Biosciences Com New (DTIL) | 3.9 | $5.2M | 385k | 13.56 | |
| Repare Therapeutics Ord (RPTX) | 2.2 | $3.0M | 633k | 4.71 |
